Lightlake Therapeutics (UK) appoints consultant Mary Pendergast as regulatory advisor
This article was originally published in SRA
Executive Summary
Lightlake Therapeutics Inc (London, UK) has appointed consultant and former senior US Food and Drug Administration official Mary Pendergast as its advisor for regulatory and strategic matters.